In a mouse model of streptozotocin-induced Alzheimer’s disease, βCAR attenuated cognitive deficit through its anti-oxidative efficacy, suppression of acetylcholinesterase, and the reduction in amyloid β-protein fragments [39]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.